Key result
Vinpocetine and pyritinol significantly improved all hemorheological parameters (P<0.05), especially low shear whole blood viscosity (P<0.01), in patients with cerebrovascular disorders.
Why the study?
Does the combination of vinpocetine and pyritinol improve blood and plasma viscosity in normotensive patients with cerebrovascular disorders?
RCT (n=30)
Does the combination of vinpocetine and pyritinol improve blood and plasma viscosity in normotensive patients with cerebrovascular disorders?
The combination of vinpocetine and pyritinol significantly improves hemorheological parameters, including low shear whole blood viscosity, in patients with cerebrovascular disorders.
Supports rheological improvement with vinpocetine-pyritinol in cerebrovascular disorders; provides RCT confirmation of hemorheological benefit.
Blood and plasma viscosity are the major factors affecting blood flow and normal circulation. Whole blood viscosity is mainly affected by plasma viscosity, red blood cell deformability/aggregation and hematocrit, and other physiological factors. Thirty patients (twenty males + ten females) with age range 50-65 years, normotensive with history of cerebrovascular disorders, were selected according to the American Heart Stroke Association. Blood viscosity and other rheological parameters were measured after two-day abstinence from any medications. Dual effects of vinpocetine and pyritinol exhibit significant effects on all hemorheological parameters (P < 0.05), especially on low shear whole blood viscosity (P < 0.01), but they produced insignificant effects on total serum protein and high shear whole blood viscosity (P > 0.05). Therefore, joint effects of vinpocetine and pyritinol improve blood and plasma viscosity in patients with cerebrovascular disorders.
No takes yet. Share an insight, caveat, or question.
Al‐kuraishy et al. (2014) conducted an RCT in Cerebrovascular disorders (n=30). Vinpocetine and pyritinol was evaluated on Hemorheological parameters (p=<0.05). Vinpocetine and pyritinol significantly improved all hemorheological parameters (P<0.05), especially low shear whole blood viscosity (P<0.01), in patients with cerebrovascular disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: